Platelet counts may be raised in giant cell arteritis' 2 but the clinical relevance of this has not been examined. We have investigated the possibility of an association between thrombocytosis and ocular or cerebral ischaemic events in giant cell arteritis.
Patients, methods, and results
We reviewed the medical records of patients with a diagnosis of giant cell arteritis who were admitted to the University Hospital of the Vrije Universiteit Brussel between 1984 and 1989 (platelet count >400 x 109/l) was found in 21 patients (37 5%). Linear regression analysis showed no correlation between platelet count and erythrocyte sedimentation rate (r=0 06) or haemoglobin concentration (r=0-15). There was no relation between thrombocytosis and positive biopsy findings in temporal arteries. In 13 patients with thrombocytosis platelet counts were remeasured two to three weeks after corticosteroid treatment had been started; values had returned to normal in all.
The group with ischaemic complications had a significantly higher prevalence of thrombocytosis (p<0-01) and a higher median platelet count (p<0-001) than the group without ischaemic complications (table).
Comment
Thrombocytosis in giant cell arteritis results from an increased production of platelets.2 Our results show an association between thrombocytosis and the occurrence of ocular and cerebral ischaemic complications in giant cell arteritis.
Reactive thrombocytosis has been detected in various other inflammatory diseases, such as rheumatoid arthritis, ankylosing spondylitis, and inflammatory bowel disease.3 The exact underlying mechanism responsible for the increase in platelet production is unknown. A first possible explanation for our findings is that thrombocytosis in giant cell arteritis reflects a more severe degree of vasculitis. We found no correlation between platelet count and erythrocyte sedimentation rate.
A second possibility is that thrombocytosis might contribute to the ischaemic complications in giant cell arteritis. However, there have been no convincing reports that ischaemic manifestations occur as a direct consequence of reactive thrombocytosis in other disorders, at least not with the rather moderate increases in platelet count detected in our patients. The lumen of arteries affected by giant cell arteritis is usually reduced by severe thickening of the intima, and thrombosis is often found at the site of active inflammation.'245 Hence we cannot exclude the possibility that in some patients with giant cell arteritis thrombocytosis may be pathologically significant in narrowed inflamed arteries. We examined the hypothesis that among subjects exposed to HIV through heterosexual activities a significantly higher proportion of secretors would become infected with the virus.
Subjects, methods, and results
We studied 219 subjects: 151 (99 men and 52 women) who acquired HIV through drug use; 14 homosexual or bisexual men; and 54 (15 men and 39 women) whose only risk factor when they entered the study was heterosexual intercourse with a partner infected with HIV.
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